Marshall Wace’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
+23,282
New +$432K ﹤0.01% 2519
2025
Q2
Sell
-39,929
Closed -$511K 3021
2025
Q1
$511K Buy
39,929
+11,419
+40% +$183K ﹤0.01% 2071
2024
Q4
$503K Sell
28,510
-754
-3% -$14.3K ﹤0.01% 2024
2024
Q3
$669K Sell
29,264
-42,372
-59% -$957K ﹤0.01% 1824
2024
Q2
$1.64M Buy
+71,636
New +$2.21M ﹤0.01% 1458
2022
Q1
Sell
-3,627
Closed -$151K 3795
2021
Q4
$151K Buy
+3,627
New +$158K ﹤0.01% 3257
2021
Q1
Sell
-5,454
Closed -$233K 2742
2020
Q4
$233K Buy
+5,454
New +$280K ﹤0.01% 1716

Other funds holding NRC

Marshall Wace's NRC Position: Q2 2026 in Review

Marshall Wace opened a new position in NRC Health Common Stock (NRC) in Q2 2026: 23,282 shares worth $502K. The stake represents ﹤0.01% of the portfolio and ranks #2519 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NRC as recently as Q1 2025.

Marshall Wace first reported a position in NRC in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.64M in Q2 2024. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Marshall Wace held 23,282 shares of NRC Health Common Stock worth $502K as of Q2 2026.
  • NRC Health Common Stock was a new Marshall Wace position in Q2 2026.
  • NRC Health Common Stock made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2519 holding.
  • Marshall Wace first reported a position in NRC Health Common Stock in Q4 2020 and has held it in 7 quarters since.
  • Marshall Wace's NRC Health Common Stock position peaked at $1.64M in Q2 2024.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.